Frontlight ResearchEarly access
Trial site
Respublikine Klaipedos ligonine VšĮ
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Asthma2 trials
- Depression2 trials
- Atrial fibrillation1 trial
- Chronic spontaneous urticaria1 trial
- COPD1 trial
- Diabetic foot ulcer1 trial
- Lupus (SLE)1 trial
- Stroke1 trial
- Phase
- Phase 38 trials
- Phase 22 trials
- Status
- Completed6 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Neurocrine Biosciences2 trials
- AbbVie1 trial
- Areteia Therapeutics Inc.1 trial
- Bayer AG1 trial
- Biotest1 trial
- and 4 more
Running trials
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression2 recruiting
Closed trials
Completed
Completed
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Terminated
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
Completed
Recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026